- Home
- GEHC vs XPO Comparison
GEHC vs XPO Comparison
Compare GEHC & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GEHC | XPO |
|---|---|---|
| Founded | 1892 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Transportation Services |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9B | 24.4B |
| IPO Year | 2022 | 2002 |
Fundamental Metrics
Financial Performance| Metric | GEHC | XPO |
|---|---|---|
| Price | $61.06 | $213.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | $88.38 | ★ $185.29 |
| AVG Volume (30 Days) | ★ 4.3M | 930.4K |
| Earning Date | 04-29-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | ★ 4.84 | N/A |
| EPS | 0.85 | 0.85 |
| Revenue | ★ $20,625,000,000.00 | $7,744,000,000.00 |
| Revenue This Year | $7.12 | $5.79 |
| Revenue Next Year | $4.45 | $6.39 |
| P/E Ratio | ★ $72.93 | $251.95 |
| Revenue Growth | ★ 4.84 | 0.34 |
| 52 Week Low | $58.75 | $116.68 |
| 52 Week High | $89.77 | $232.05 |
Technical Indicators
Market Signals| Indicator | GEHC | XPO |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 54.93 |
| Support Level | $60.17 | $196.67 |
| Resistance Level | $65.83 | $220.50 |
| Average True Range (ATR) | 1.89 | 6.55 |
| MACD | -0.33 | 0.93 |
| Stochastic Oscillator | 18.40 | 75.26 |
Price Performance
Historical ComparisonAbout GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. We estimate LTL shipping makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.